Travere Therapeutics (TVTX) Operating Income Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.94% |
| Dec 31, 2025 | 22.84% |
| Sep 30, 2025 | 26.84% |
| Jun 30, 2025 | 11.35% |
| Mar 31, 2025 | -23.15% |
| Dec 31, 2024 | -16.61% |
| Sep 30, 2024 | -10.27% |
| Jun 30, 2024 | -13.13% |
| Mar 31, 2024 | -29.50% |
| Dec 31, 2023 | -80.01% |
| Sep 30, 2023 | -21.08% |
| Jun 30, 2023 | -36.97% |
| Mar 31, 2023 | -40.30% |
| Dec 31, 2022 | -41.70% |
| Sep 30, 2022 | -50.76% |
| Jun 30, 2022 | -42.01% |
| Mar 31, 2022 | -37.95% |
| Dec 31, 2021 | -36.02% |
| Sep 30, 2021 | -9.25% |
| Jun 30, 2021 | -25.42% |
| Mar 31, 2021 | -41.98% |
| Dec 31, 2020 | -50.80% |
| Sep 30, 2020 | 1.06% |
| Jun 30, 2020 | -27.19% |
| Mar 31, 2020 | -13.20% |
| Dec 31, 2019 | -8.54% |
| Sep 30, 2019 | -9.51% |
| Jun 30, 2019 | -16.28% |
| Mar 31, 2019 | -11.62% |
| Dec 31, 2018 | 15.60% |
| Sep 30, 2018 | -42.62% |
| Jun 30, 2018 | -38.60% |
| Mar 31, 2018 | -51.42% |